HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Koo Selected Research

Clobetasol (Clobetasol Propionate)

1/2016An open label pilot study of supraerythemogenic excimer laser in combination with clobetasol spray and calcitriol ointment for the treatment of generalized plaque psoriasis.
9/2013A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
8/2011Yin-yang strategy: proposing a new, effective, repeatable, sequential therapy for psoriasis.
10/2006A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes.
11/2002Vitamin D and scalp psoriasis.
5/2002A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Koo Research Topics

Disease

91Psoriasis (Pustulosis Palmaris et Plantaris)
03/2022 - 05/2002
10Pruritus (Itching)
02/2021 - 12/2003
9Erythema
04/2020 - 12/2003
9Atopic Dermatitis (Atopic Eczema)
05/2017 - 11/2006
8Skin Diseases (Skin Disease)
04/2020 - 05/2005
6Psoriatic Arthritis
01/2021 - 05/2009
5Eczema
05/2017 - 05/2005
4Headache (Headaches)
01/2017 - 01/2015
4Nasopharyngitis
01/2017 - 08/2015
4Vitiligo
08/2014 - 05/2005
4Neoplasms (Cancer)
08/2013 - 03/2004
3Respiratory Tract Infections (Respiratory Tract Infection)
03/2016 - 01/2015
3Skin Neoplasms (Skin Cancer)
01/2015 - 05/2005
2Body Dysmorphic Disorders (Body Dysmorphic Disorder)
09/2021 - 01/2004
2Inflammation (Inflammations)
02/2021 - 03/2018
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2018 - 05/2017
2Rheumatoid Arthritis
03/2018 - 05/2009
2Mental Disorders (Mental Disorder)
01/2018 - 12/2016
2Drug-Related Side Effects and Adverse Reactions
01/2017 - 01/2016
2Infections
01/2017 - 08/2015
2Demyelinating Diseases (Demyelinating Disease)
10/2016 - 01/2009
2Injection Site Reaction
03/2016 - 01/2015
2Autoimmune Diseases (Autoimmune Disease)
08/2014 - 08/2008
1Hypersensitivity (Allergy)
05/2022
1Narcissistic Personality Disorder
05/2022
1Borderline Personality Disorder (Personality Disorders, Borderline)
05/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2022
1Exfoliative Dermatitis (Erythroderma)
02/2021
1Weight Loss (Weight Reduction)
01/2018
1Wounds and Injuries (Trauma)
01/2018
1Overweight
01/2018
1Cushing Syndrome
07/2017
1Arthritis (Polyarthritis)
05/2017
1Pain (Aches)
01/2017
1Arthralgia (Joint Pain)
01/2017
1Hallucinations (Hallucination)
12/2016
1Polyneuropathies (Polyneuropathy)
10/2016
1Multiple Sclerosis
10/2016

Drug/Important Bio-Agent (IBA)

17Biological ProductsIBA
02/2021 - 05/2005
9Etanercept (Enbrel)FDA Link
10/2016 - 04/2007
8brodalumabIBA
12/2020 - 10/2015
8Adalimumab (Humira)FDA Link
10/2016 - 04/2007
8RetinoidsIBA
03/2012 - 12/2003
7calcipotriene (calcipotriol)FDA LinkGeneric
03/2022 - 11/2002
7Ointments (Pastes)IBA
01/2017 - 10/2006
7Pharmaceutical PreparationsIBA
12/2016 - 07/2003
6Monoclonal AntibodiesIBA
01/2018 - 01/2009
6Ustekinumab (CNTO 1275)FDA Link
01/2017 - 12/2014
6Ficusin (Psoralen)IBA
09/2016 - 03/2004
6Clobetasol (Clobetasol Propionate)FDA LinkGeneric
01/2016 - 05/2002
5betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
03/2022 - 01/2016
5SteroidsIBA
04/2020 - 06/2015
5apremilastIBA
05/2017 - 06/2015
5Infliximab (Remicade)FDA Link
05/2017 - 02/2014
5Interleukin-17 (Interleukin 17)IBA
01/2017 - 03/2014
5Adrenal Cortex Hormones (Corticosteroids)IBA
08/2014 - 05/2002
4AerosolsIBA
08/2020 - 01/2016
4Vitamin DFDA LinkGeneric
01/2018 - 11/2002
4Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2017 - 07/2002
4InterleukinsIBA
01/2017 - 10/2015
4ixekizumabIBA
01/2017 - 02/2015
4AcitretinFDA Link
04/2011 - 08/2005
4efalizumab (Raptiva)FDA Link
01/2009 - 10/2003
3Prostaglandins AIBA
03/2022 - 10/2015
3Coal Tar (Estar)IBA
02/2021 - 02/2013
2Doxepin (Mareen)FDA LinkGeneric
02/2021 - 01/2018
2CytokinesIBA
03/2018 - 02/2015
2Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
05/2017 - 03/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2017 - 10/2016
2secukinumabIBA
01/2017 - 03/2016
2Tumor Necrosis Factor InhibitorsIBA
10/2016 - 05/2009
2Interleukin-23 (Interleukin 23)IBA
03/2016 - 10/2015
2Calcitriol (Calcijex)FDA LinkGeneric
01/2016 - 08/2011
2Immunosuppressive Agents (Immunosuppressants)IBA
09/2014 - 03/2012
2HydrogelsIBA
04/2013 - 09/2011
2Tacrolimus (Prograf)FDA LinkGeneric
10/2012 - 11/2006
2SolutionsIBA
11/2002 - 05/2002
1Dopamine Receptors (Dopamine Receptor)IBA
05/2022
1neodymium pyrocatechin disulfonate (NPD)IBA
05/2022
1SuspensionsIBA
03/2022
1Biological FactorsIBA
09/2021
17,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
09/2021
1WaxesIBA
04/2020
1Interleukin-17 ReceptorsIBA
01/2018
1CalciumIBA
06/2017
1SugarsIBA
06/2017
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
05/2017
1tildrakizumabIBA
01/2017
1guselkumabIBA
01/2017
1Illicit Drugs (Recreational Drugs)IBA
12/2016

Therapy/Procedure

38Therapeutics
04/2022 - 11/2002
22Phototherapy (Light Therapy)
02/2021 - 05/2005
9Excimer Lasers
04/2020 - 08/2007
6Biological Therapy
01/2017 - 05/2005
2Aftercare (After-Treatment)
01/2019 - 07/2002
2Photochemotherapy (Photodynamic Therapy)
09/2016 - 06/2010
2Injections
09/2016 - 08/2014
2Lasers (Laser)
02/2015 - 01/2010
2PUVA Therapy
11/2009 - 12/2005
1Vagus Nerve Stimulation
03/2018